WebCHIR-98014 is a potent, selective and ATP-competitive inhibitor of GSK3α and GSK3β (IC₅₀ = 0.65 and 0.58 nM, respectively). In addition, CHIR-98014 displays 500 to greater than … WebBromo- and extra-terminal domain inhibitors (BETi) have exhibited therapeutic activities in many cancers. However, the mechanisms controlling BETi response and resistance are not well understood. We conducted genome-wide loss-of-function CRISPR screens using BETi-treated KMT2A-rearranged (KMT2A-r) c …
9-ing-41 ≥99%(HPLC) Selleck GSK-3 inhibitor
WebCHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC 50 values of 0.65 nM and 0.58 nM for GSK3α and GSK3β, respectively. CHIR98014 is 500-fold to >10,000-fold selectivity for GSK-3 versus 20 other protein kinases tested, including closest homologs Cdc2 and ERK2. WebCHIR 98014. Synonym (s): N-6- [2- [ [4- (2,4-Dichlorophenyl)-5- (1H-imidazol-1-yl)-2-pyrimidinyl]amino]ethyl]-3-nitro-2,6-pyridinediamine, CHIR-98014. Empirical Formula (Hill … the pow wow book
CHIR-98014 CAS 252935-94-7 AbMole BioScience CHIR-98014 …
WebCHIR 98014 is a highly potent and selective GSK-3 inhibitor (IC 50 values are 0.58 and 0.65 nM for the β and α isoforms, respectively). Exhibits >500-fold selectivity for GSK-3β over … WebCHIR 98014 is a glycogen synthase kinase-3 (GSK-3) inhibitor with IC 50 values of 0.65 nM and 0.58 nM for GSK3α and GSK3β, respectively. CHIR98014 is 500-fold to >10,000 … WebCHIR-98014: 40: 875446-37-0 Anacetrapib(MK-0859) 41: 452342-67-5 GW788388: 42: 936091-26-8 ... the powwow guy